发明公开
- 专利标题： NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR
- 专利标题（中）： 血栓形成细胞激活剂的胶原蛋白
-
申请号： EP07744900.7申请日： 2007-06-07
-
公开(公告)号： EP2025671A1公开(公告)日： 2009-02-18
- 发明人: MIYAJI, Katsuaki , IWAMOTO, Shunsuke , SHIGETA, Yukihiro , HIROKAWA, Yutaka , OOWADA, Shingo , NAKAMURA, Takanori , ISHIWATA, Norihisa
- 申请人： Nissan Chemical Industries, Ltd.
- 申请人地址： 7-1, Kanda Nishiki-cho 3-chome Chiyoda-ku, Tokyo 101-0054 JP
- 专利权人： Nissan Chemical Industries, Ltd.
- 当前专利权人： Nissan Chemical Industries, Ltd.
- 当前专利权人地址： 7-1, Kanda Nishiki-cho 3-chome Chiyoda-ku, Tokyo 101-0054 JP
- 代理机构： Hartz, Nikolai
- 优先权： JP2006158459 20060607
- 国际公布： WO2007142308 20071213
- 主分类号： C07D231/22
- IPC分类号： C07D231/22 ; A61K31/454 ; A61K31/496 ; A61P7/00 ; A61P7/04 ; A61P9/00 ; A61P9/10 ; A61P43/00 ; C07D401/12
摘要：
Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided.
A compound represented by the formula (I) (wherein R 1 , R 2 , R 3 , L 1 , L 2 , L 3 , X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
A compound represented by the formula (I) (wherein R 1 , R 2 , R 3 , L 1 , L 2 , L 3 , X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
信息查询
